Skip to content

ImmuCell Corporation: 10-K filed 2014-03-26

What ImmuCell Corporation reported in its annual report filed 2014-03-26 (fiscal FY 2013): 38 published measures, 171 facts as tagged in accession 0001144204-14-017813.

This filing

Form
10-K (annual report)
Filed
2014-03-26
Fiscal period
fiscal FY 2013
Accession
0001144204-14-017813 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ImmuCell Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3110,960,714USD
At 2012-12-3111,030,407USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-311,564,845USD
At 2012-12-311,835,724USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-319,395,869USD
At 2012-12-319,194,683USD
At 2011-12-319,020,433USD
At 2010-12-319,282,401USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-312,270,385USD
At 2012-12-312,673,719USD
At 2011-12-31781,516USD
At 2010-12-311,398,985USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-150,703USD92
2013-01-01 to 2013-12-31117,395USD365
2013-07-01 to 2013-09-3057,336USD92
2013-04-01 to 2013-06-306,452USD91
2013-01-01 to 2013-03-31204,310USD90
2012-10-01 to 2012-12-31-16,862USD92
2012-01-01 to 2012-12-3189,512USD366
2012-07-01 to 2012-09-30-63,574USD92
2012-04-01 to 2012-06-3015,187USD91
2012-01-01 to 2012-03-31154,761USD91
2011-10-01 to 2011-12-31-530USD92
2011-01-01 to 2011-12-31-409,510USD365
2011-07-01 to 2011-09-30-127,649USD92
2011-04-01 to 2011-06-30-258,218USD91
2011-01-01 to 2011-03-31-23,113USD90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-12-31597,697USD365
2012-01-01 to 2012-12-31275,395USD366
2011-01-01 to 2011-12-31243,735USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-407,408USD
At 2012-12-31-524,803USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,019,407shares365
2012-01-01 to 2012-12-313,018,296shares366
2011-01-01 to 2011-12-312,984,749shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,085,048shares365
2012-01-01 to 2012-12-313,108,419shares366
2011-01-01 to 2011-12-312,984,749shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-0.05USD/shares92
2013-01-01 to 2013-12-310.04USD/shares365
2013-07-01 to 2013-09-300.02USD/shares92
2013-04-01 to 2013-06-300USD/shares91
2013-01-01 to 2013-03-310.07USD/shares90
2012-10-01 to 2012-12-31-0.01USD/shares92
2012-01-01 to 2012-12-310.03USD/shares366
2012-07-01 to 2012-09-30-0.02USD/shares92
2012-04-01 to 2012-06-300.01USD/shares91
2012-01-01 to 2012-03-310.05USD/shares91
2011-10-01 to 2011-12-310USD/shares92
2011-01-01 to 2011-12-31-0.14USD/shares365
2011-07-01 to 2011-09-30-0.04USD/shares92
2011-04-01 to 2011-06-30-0.09USD/shares91
2011-01-01 to 2011-03-31-0.01USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-0.05USD/shares92
2013-01-01 to 2013-12-310.04USD/shares365
2013-07-01 to 2013-09-300.02USD/shares92
2013-04-01 to 2013-06-300USD/shares91
2013-01-01 to 2013-03-310.07USD/shares90
2012-10-01 to 2012-12-31-0.01USD/shares92
2012-01-01 to 2012-12-310.03USD/shares366
2012-07-01 to 2012-09-30-0.02USD/shares92
2012-04-01 to 2012-06-300.01USD/shares91
2012-01-01 to 2012-03-310.05USD/shares91
2011-10-01 to 2011-12-310USD/shares92
2011-01-01 to 2011-12-31-0.14USD/shares365
2011-07-01 to 2011-09-30-0.04USD/shares92
2011-04-01 to 2011-06-30-0.09USD/shares91
2011-01-01 to 2011-03-31-0.01USD/shares90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-12-3187,865USD365
2012-01-01 to 2012-12-31102,640USD366
2011-01-01 to 2011-12-31-287,171USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-312,524,765USD
At 2012-12-312,357,609USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-3131,359USD365
2012-01-01 to 2012-12-3135,985USD366
2011-01-01 to 2011-12-3138,172USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-209,975USD92
2013-01-01 to 2013-12-31-19,552USD365
2013-07-01 to 2013-09-30-159,967USD92
2013-04-01 to 2013-06-3023,722USD91
2013-01-01 to 2013-03-31326,666USD90
2012-10-01 to 2012-12-3112,497USD92
2012-01-01 to 2012-12-31245,001USD366
2012-07-01 to 2012-09-30-86,126USD92
2012-04-01 to 2012-06-3037,397USD91
2012-01-01 to 2012-03-31281,233USD91
2011-10-01 to 2011-12-319,382USD92
2011-01-01 to 2011-12-31-632,726USD365
2011-07-01 to 2011-09-30-192,390USD92
2011-04-01 to 2011-06-30-432,860USD91
2011-01-01 to 2011-03-31-16,858USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-317,267,632USD
At 2012-12-317,363,182USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-31635,619USD
At 2012-12-31665,770USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-12-31152,153USD
At 2012-12-31228,711USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-31631,410USD
At 2012-12-31611,354USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,080,158USD365
2012-01-01 to 2012-12-312,809,258USD366
2011-01-01 to 2011-12-313,446,530USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-311,206,508USD
At 2012-12-311,649,002USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-31607,644USD92
2013-01-01 to 2013-12-313,060,606USD365
2013-07-01 to 2013-09-30615,717USD92
2013-04-01 to 2013-06-30783,677USD91
2013-01-01 to 2013-03-311,053,567USD90
2012-10-01 to 2012-12-31750,215USD92
2012-01-01 to 2012-12-313,054,259USD366
2012-07-01 to 2012-09-30620,958USD92
2012-04-01 to 2012-06-30670,518USD91
2012-01-01 to 2012-03-311,012,568USD91
2011-10-01 to 2011-12-31725,009USD92
2011-01-01 to 2011-12-312,813,804USD365
2011-07-01 to 2011-09-30526,034USD92
2011-04-01 to 2011-06-30694,526USD91
2011-01-01 to 2011-03-31868,235USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-10-01 to 2013-12-31325,010USD92
2013-01-01 to 2013-12-311,154,200USD365
2013-07-01 to 2013-09-30290,853USD92
2013-04-01 to 2013-06-30271,858USD91
2013-01-01 to 2013-03-31266,479USD90
2012-10-01 to 2012-12-31234,316USD92
2012-01-01 to 2012-12-31917,600USD366
2012-07-01 to 2012-09-30223,771USD92
2012-04-01 to 2012-06-30211,706USD91
2012-01-01 to 2012-03-31247,807USD91
2011-10-01 to 2011-12-31271,076USD92
2011-01-01 to 2011-12-311,720,055USD365
2011-07-01 to 2011-09-30304,082USD92
2011-04-01 to 2011-06-30672,763USD91
2011-01-01 to 2011-03-31472,134USD90

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-31-19,836USD
At 2012-12-31-50,120USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-12-31929,226USD
At 2012-12-311,169,954USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-316,536,768USD
At 2012-12-316,178,236USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-314,012,003USD
At 2012-12-313,820,627USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-3113,636USD
At 2012-12-3163,634USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-31293,076USD
At 2012-12-31255,568USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31205,260USD365
2012-01-01 to 2012-12-31192,152USD366
2011-01-01 to 2011-12-31-696,681USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31939,192USD365
2012-01-01 to 2012-12-31918,441USD366
2011-01-01 to 2011-12-31856,606USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-31414,307USD365
2012-01-01 to 2012-12-31399,640USD366
2011-01-01 to 2011-12-31413,132USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-31224,812USD365
2012-01-01 to 2012-12-31-52,849USD366
2011-01-01 to 2011-12-31-63,955USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2013-01-01 to 2013-12-31301USD365
2012-01-01 to 2012-12-31708USD366
2011-01-01 to 2011-12-31510USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-01-01 to 2013-12-3187,166USD365
2012-01-01 to 2012-12-3194,370USD366
2011-01-01 to 2011-12-31-302,500USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-3121,540USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-442,494USD365
2012-01-01 to 2012-12-31-17,463USD366
2011-01-01 to 2011-12-3165,449USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-95,503USD365
2012-01-01 to 2012-12-31100,047USD366
2011-01-01 to 2011-12-3159,479USD365

Inspect the source

Entity
ImmuCell Corporation / CIK 0000811641
Captured
2026-09-19T15:06:16.277Z
SEC response SHA-256
e6fd54c346f29af23b63003a8b733aa2d9275cd6689854dc3a6eebcd0ca809e7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000811641.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))